SCHEMBL454533

SCHEMBL454533

[c]1ccc2[nH][c]cc2c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL449275 0.80
SCHEMBL9203718 0.69 ALDH1A1 (0.52)
SCHEMBL23566 0.68
SCHEMBL129202 0.68
SCHEMBL20424853 0.67 AHR (0.44)
SCHEMBL71297 0.66
SCHEMBL445877 0.65 CYP2A6 (0.48)
SCHEMBL23081 0.65
SCHEMBL4460967 0.65 F11 (0.31)
SCHEMBL2452605 0.65 DAO (0.31)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 125 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118076602-A Heteroaryl-acetylenes, pharmaceutical compositions thereof and their therapeutic uses 嘉兴优博生物技术有限公司 2024-05-24 CN claimed
US-20240101546-A1 HETEROARYL-ACETYLENES, PHARMACEUTICAL COMPOSITIONS THEREOF, AND THEIR THERAPEUTIC APPLICATIONS EUBULUS BIOTHERAPEUTICS INC (CN) 2024-03-28 US claimed
EP-3521292-A1 BIFUNCTIONAL CYTOTOXIC AGENTS Pfizer Inc (US) 2019-08-07 EP claimed
US-20180339060-A1 BIFUNCTIONAL CYTOTOXIC AGENTS PFIZER INC. (US) 2018-11-29 US claimed
CN-106459055-A Bifunctional cytotoxic agents 辉瑞大药厂 2017-02-22 CN claimed
EP-3099692-A1 BIFUNCTIONAL CYTOTOXIC AGENTS Pfizer Inc. (US) 2016-12-07 EP claimed
US-20150209445-A1 BIFUNCTIONAL CYTOTOXIC AGENTS PFIZER INC. 2015-07-30 US claimed
WO-2015110935-A1 BIFUNCTIONAL CYTOTOXIC AGENTS PFIZER INC. (US) 2015-07-30 WO claimed
US-7566781-B2 Imidazopyridine compound BANYU PHARMACEUTICAL CO., LTD. (JP) 2009-07-28 US claimed
US-20070249659-A1 melanin concentrating hormone receptor antagonist; preventing or treating vascular system diseases, nervous system disorders, metabolic disorders, urogenital diseases, respiratory diseases disorders; N-(2-ethyl-3-methylimidazo[1,2-a]pyridin-6-yl)-3-fluoro-4-(pyridin-2-ylmethoxy)benzamide BANYU PHARMACEUTICAL., LTD. (JP) 2007-10-25 US claimed
EP-1208089-B1 DIAZOCIN-DIONE DERIVATIVES AND THEIR USE AS TRYPTASE INHIBITORS ALTANA PHARMA AG (DE) 2004-10-13 EP claimed
US-6693098-B2 CARBOXYLIC ACID OR TETRAZOLE DERIVATIVES CONTAINING CARBAMATE GROUPS ARE USEFUL FOR TREATING THE CONDITIONS ASSOCIATED WITH THE URINARY TRACT, PAIN, INFLAMMATION, RESPIRATORY STATES, EDEMA FORMATION OF HYPOTENSIVE VASCULAR DISEASES SYNTEX (U.S.A) LLC 2004-02-17 US claimed
EP-1216236-A1 TRYPTASE INHIBITORS Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2002-06-26 EP claimed
EP-1115731-A2 NOVEL PYRANOSES Byk Gulden Lomberg Chemische Fabrik GmbH (DE) 2001-07-18 EP claimed
WO-2001019809-A1 TRYPTASE INHIBITORS BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2001-03-22 WO claimed
EP-0359454-B1 CC-1065 analogs having two CPI subunits UPJOHN CO (US) 2000-12-27 EP claimed
WO-2000014097-A2 NOVEL PYRANOSES BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH (DE) 2000-03-16 WO claimed
US-5541339-A ANTITUMOR AGENTS THE UPJOHN COMPANY (US) 1996-07-30 US claimed
WO-1990002746-A1 NOVEL CC-1065 ANALOGS HAVING TWO CPI SUBUNITS THE UPJOHN COMPANY (US) 1990-03-22 WO claimed
EP-0359454-A1 Novel CC-1065 analogs having two CPI subunits THE UPJOHN COMPANY (US) 1990-03-21 EP claimed